Skip to main content
Deep teal background with dose comparison bar chart motif and estradiol patch shapes, representing the low dose HRT online guide

Low Dose HRT Online: What It Means, What It Costs, and Who Will Actually Follow Up

You can get low dose HRT online. A licensed clinician has to evaluate you first — that part is real, not a formality. But "low dose" is not one number.

By The HRT Index Editorial TeamLast verified: Educational only — not medical advice
HI
The HRT Index Editorial TeamIndependent women's health research
Published: Last reviewed:
Editorial research — not medically reviewed by a clinician. Why this label

Last updated: · Last verified: · Every price, dose, and label claim below is sourced and dated.

Introduction

It’s a strength inside one specific product, and the numbers don’t transfer between products.

  • Some once-weekly estradiol patches start hot flash treatment at 0.025 mg/day.
  • Some twice-weekly patches start at 0.0375 mg/day — and use 0.025 for bone loss instead, not hot flashes.
  • Divigel gel starts at 0.25 mg.
  • Bijuva starts at 0.5 mg estradiol with 100 mg progesterone.

Four “low doses.” Four different products. You can’t compare them by looking at the numbers.

One more thing, from the FDA’s own trial data:

The lowest dose of Divigel didn’t clearly beat a sugar pill until week 7. Not week 2. Week 7. That number changes what you should be asking a provider.

Who may be a candidate for low dose HRT online?

Online care may be a reasonable starting point if you:

  • Are under 60, or within 10 years of your last period — updated FDA labeling now says to consider starting systemic HRT in this window
  • Have hot flashes or night sweats disrupting your life
  • Got told “you’re too young” or “your labs are normal” and want a real evaluation
  • Want to start conservatively and reassess

These timing factors make the conversation more favorable. They don’t decide it for you.

Start with an in-person clinician instead if you have:

  • Breast cancer, now or in the past
  • Blood clots (DVT or PE), stroke, or heart attack
  • Vaginal bleeding you can’t explain
  • Liver disease
  • A known clotting disorder

Unexplained bleeding especially. The label requires ruling out cancer before systemic estrogen. Not “consider.” Requires.

Which low dose HRT provider fits your situation?

The right online HRT provider isn’t the same for every woman — it depends on your symptoms, your age, whether you have a uterus, your route preference, your risk history, your insurance or cash-pay situation, and your state.

Find My HRT Path →

The HRT Index is the independent decision resource for online menopause and HRT care — comparing providers on clinical legitimacy, care quality, medication fit, price transparency, and access.

What does “low dose HRT” actually mean?

“Low dose” is not an FDA category. It refers to a lower marketed or labeled strength within one specific product, and those strengths cannot be compared across products.

Estradiol is the main estrogen your ovaries used to make. Systemicmeans it circulates through your whole body — that’s the kind that touches hot flashes. If you have a uterus, it’s usually estrogen plus a progestogen.

Published sources contradict each other — some call 1 mg oral “low dose,” others call 0.5 mg “low dose.” Those definitions don’t even overlap. So we stopped reading health sites and went to the labels.

Examples of product-specific labeled strengths

Not equivalent doses. Not a self-start guide.

Product typeLabeled strength exampleLabeled forWatch out
Once-weekly estradiol patch0.025 mg/daySome labels start vasomotor-symptom treatment hereProduct-specific. Don’t assume every patch
Twice-weekly estradiol patch0.0375 mg/daySome labels start vasomotor-symptom treatment here0.025 mg/day may be the osteoporosis-prevention dose on these, not the hot flash dose
Menostar patch0.014 mg/dayOsteoporosis prevention onlyNot labeled for hot flashes. See section below
Divigel (estradiol gel)0.25 mgLabeled starting dose for hot flashesThe one product with a published week-by-week curve
Oral estradiol tablet0.5 mg is a marketed strengthOne generic label states a usual initial hot flash dose of 1–2 mg daily0.5 mg exists — it isn’t the universal labeled starting dose
Bijuva (estradiol + progesterone)0.5 mg / 100 mgLabeled starting strengthSpecific to Bijuva. Doesn’t transfer to separate pills
Premarin (conjugated estrogens)0.3 mgGenerally starts hot flash treatment hereProduct-specific. Not every conjugated estrogen starts here

Sources: FDA and DailyMed prescribing information for each product. Accessed July 14, 2026.

The distinction nobody makes

A once-weekly patch and a twice-weekly patch can have completely different labeled starting doses for the same symptom. On some twice-weekly patches, 0.025 mg/day is the bone dose, and hot flash treatment starts at 0.0375.

Ask this instead: “What’s the labeled starting dose for hot flashes on the exact patch you’re prescribing me?”

Why you can’t compare numbers across routes

A 0.025 mg patch and a 0.5 mg pill look wildly different. A patch goes through your skin, straight into your blood. A pill goes through your stomach and liver first (first-pass metabolism) and much is processed before reaching the rest of you. The numbers on the boxes are measuring different things.

The number on the box isn’t the amount that reaches your body. Compare within a product line. Never across.

What “low dose” does not mean

The lowest-dose patch isn’t labeled for hot flashes

Menostar delivers 0.014 mg of estradiol per day — the lowest-dose estradiol patch sold in the U.S. Its labeled indication is prevention of postmenopausal osteoporosis. It is not FDA-labeled to treat hot flashes.

If you go hunting for the lowestdose, you can land on Menostar. Real product. Real FDA approval. Smallest number on the shelf. Prescribing it for hot flashes would be off-label — and the osteoporosis indication doesn’t establish that it works for hot flashes, because that’s not what it was approved on.

So if it doesn’t help your hot flashes, that tells you nothing about whether HRT would. You’d be judging systemic hormone therapy on a product that was never labeled to do the thing you wanted done.

If someone offers you the 0.014 mg patch for hot flashes, ask why. There may be a good reason. You should hear it.

Is low dose HRT safer? What the FDA actually changed in 2026

In February 2026, FDA approved labeling changes to six menopausal hormone therapy products, removing boxed-warning language about cardiovascular disease, breast cancer, and probable dementia. It retained the boxed endometrial cancer warning for systemic estrogen-alone products. It did not declare hormone therapy safe for everyone.
Nov 10, 2025FDA requests the labeling changes; asks manufacturers to submit
Feb 12, 2026FDA approves changes on the first batch: six products
RemovedCardiovascular disease, breast cancer, probable dementia language from the boxed warning
RetainedThe boxed endometrial cancer warning for systemic estrogen-alone products
AddedLanguage to consider starting systemic HRT in women under 60 or within 10 years of menopause onset

Our one honest admission — and it’s about the news, not a provider

The FDA did not say hormone therapy is safe.A lot of pages are telling you it did. Section 5.1 of the updated Divigel label still describes increased risk of blood clots and stroke. That information didn’t disappear — it moved out of the boxed warning and into the regular warnings section.

What the Menopause Society actually said is specific: risks are low for younger, healthy women starting closer to the menopause transition, and greater for older women further out. That’s more useful than “it’s all fine now.”

Which products actually have the new label

FDA asked 29 companies to submit changes. As of , six products had been approved. FDA’s tracking page is still marked “content current as of 02/12/2026.”

ProductCategory
Divigel (estradiol gel)Systemic estrogen alone
Cenestin (synthetic conjugated estrogens A)Systemic estrogen alone
Enjuvia (synthetic conjugated estrogens B)Systemic estrogen alone
Bijuva (estradiol + progesterone)Systemic combination
Prometrium (progesterone)Progestogen alone
Estring (estradiol vaginal ring)Topical vaginal

Source: FDA, “Menopausal Hormone Therapies with Updated Prescribing Information.” Content current as of 02/12/2026. Accessed .

So here’s what may happen to you

You read that the FDA removed the scary warning. You get prescribed a patch. You open the box. And there’s the old warning — breast cancer, dementia, heart disease — right there in your hand at 9pm.

Nothing went wrong.Labels are updated product by product, manufacturer by manufacturer. FDA approved the first six in February. Most haven’t come through yet. The label in your box is the one that legally applies to your medication.

Does low dose HRT reduce risk?

Dose is one of several interacting factors affecting benefit and risk. Route may affect thrombotic risk because transdermal estradiol avoids first-pass hepatic metabolism. Progestogen status determines endometrial risk if you have a uterus. Timing — how long since menopause — is an important part of the assessment.

You think dose is the safety dial. It’s one dial among several, and the others aren’t quieter.

The factorWhat it affects
DoseSymptom relief and how fast. Endometrial risk from unopposed estrogen rises with dose and duration.
Route (patch vs. pill)May affect clot risk. Transdermal avoids first-pass liver metabolism — that's the biologic reason.
ProgestogenEndometrial risk, if you have a uterus. Needed with systemic estrogen regardless of how low the dose is.
TimingAn important part of the benefit-risk assessment. Now on updated labels.
Your historyWhether systemic hormone therapy is an option at all.

Make it concrete.

Picture two women. One takes a low dose of oral estrogen, started at 66, fifteen years after menopause. The other takes a standard-dose patch, started at 51.

Dose alone cannot tell you which of those is the safer situation. She picked the smaller number. Not the safer one. Those aren’t the same decision.

If you take one thing from this page:ask about route and timing with the same energy you’re bringing to dose.

Does that timing profile sound like you?

Under 60. Within 10 years of your last period. No history of clots or breast cancer. Tired of being told to ride it out.

You’re not early. You’re on time.

Find My HRT Path →

Answer a few questions and get a plan you can bring to a consult, including a flag if online care isn’t your right first step.

Do you need systemic HRT, or vaginal estrogen?

Low-dose vaginal estrogen targets genitourinary symptoms — dryness, irritation, painful sex — with low, product-specific systemic exposure. Systemic HRT is what’s labeled for hot flashes and night sweats.

We’re putting this here because some of you are about to buy the wrong thing.

What’s actually bothering youLikely discussionWhere to go
Hot flashes, night sweats, waking up soakedSystemic — patch, pill, or gelKeep reading
Dryness, burning, sex hurts, recurring UTIs — mostly thatLocal vaginal estrogenVaginal estrogen guide →
BothCould be either or both. Needs a real conversationFind My HRT Path →
Complex historyIn-person assessment firstSee in-person section below

Two things worth knowing:

Vaginal estrogen generally doesn’t need a progestogen. The Menopause Society doesn’t recommend adding one with recommended low-dose vaginal estrogen.

The Menopause Society explicitly supported removing the boxed warning for low-dose vaginal estrogen — its language was that the warning may have deterred women from a safe and effective therapy for a condition most menopausal women get.

If the dryness/irritation row is you — go. Vaginal estrogen guide. We’d rather lose you to the right page than convert you onto the wrong drug.

Do you still need progesterone on low dose estrogen?

If you have a uterus and use systemic estrogen, the regimen generally needs adequate endometrial protection — at any dose, including the lowest. This is the boxed warning the FDA retained in 2026.

Progestogen is the family of medications that protects your uterine lining from estrogen. Progesterone is the specific member that matches what your body made.

If you have a uterus and you’re on systemic estrogen, you need endometrial protection. Not at higher doses only. Systemic estrogen without it can increase the risk of endometrial hyperplasia and cancer. That’s why the FDA kept this one warning when it deleted the others.

There is no universal 100 mg rule

The progesterone capsule label’s regimen for endometrial protection is 200 mg at bedtime for 12 days per 28-day cycle, alongside daily conjugated estrogen. That’s what’s approved for that indication.

100 mgis a real capsule strength, and 100 mg daily is what’s inside Bijuva — an approved combination product. Many clinicians also prescribe 100 mg daily continuously. That’s common practice. But common practice and the labeled regimen aren’t the same thing. Ask which one you’re being given.

If you’ve had a hysterectomy, you generally don’t need a progestogen. But if you have a history of endometriosis, say so at your consult — Divigel’s updated label notes some women without a uterus but with endometriosis history may benefit from one.

Red flag:if any provider offers you systemic estrogen without asking whether you have a uterus, that’s a serious problem. Walk.

See also: HRT after hysterectomy.

How long did the lowest Divigel dose take to work?

In the Divigel trial, the 0.25 mg dose did not reach statistical significance versus placebo on hot flash frequency or severity at week 4. Both reached significance by week 7. This result is specific to Divigel 0.25 mg and does not establish a timeline for any other product, route, or individual.

The trial: 495 postmenopausal women. Median age 54.6. Every one having at least 50 moderate-to-severe hot flashes a week. Randomized, placebo-controlled.

Divigel clinical trial efficacy — DIVIGEL prescribing information, Table 3, Section 14.1. FDA, revised February 2026.
Divigel doseWeek 4 frequencyWeek 4 severityWeek 7Median severity change at week 12
0.25 mg (lowest)✕ p=0.132✕ p=0.283✓ Both significant−0.33
0.5 mg✓ p=0.011✓ p<0.001✓ Both significant−0.56
1.0 mg✓ p<0.001✓ p<0.001✓ Both significant−1.69
Placebo−0.13

The two mistakes

Quitting at week 3.No clear improvement by week 3 doesn’t establish that a lowest dose has failed. On Divigel 0.25 mg, week 3 is before the data showed separation at all. You’d be quitting on a question that hadn’t been answered yet.

Assuming week 12 is the ceiling.If symptoms are still disruptive at follow-up, that’s information — not a verdict. It might mean the dose, the route, adherence, a side effect, or something else. It means go back and say so.

Low dose is a starting point. It’s only a destination if it actually works.

Why the same dose does different things to different women

Divigel serum estradiol exposure — prescribing information, Table 2, Section 12.3.
Divigel doseAverage levelVariation between participants
0.25 mg9.8 pg/mL92%
0.5 mg21 pg/mL148%
1.0 mg30.5 pg/mL81%

That last column is the coefficient of variation. The same dose produced substantially different measured exposure in different women.That’s FDA data. The label goes further: serum estrogen concentrations do not predict an individual woman’s response to Divigel.

Also from the label (Section 5.20): serum FSH and estradiol levels have not been shown useful in managing moderate-to-severe hot flashes. If someone wants to sell you a hormone panel to pick your hot flash dose, that’s not what the label supports. Ask why.

Is “low and slow” still the right approach?

Current guidance emphasizes the lowest effectivedose, individualized duration, and periodic reevaluation — not an automatic rule to keep every woman at the lowest marketed strength or stop at a fixed date. FDA’s 2025 requested labeling changes removed “lowest effective dose for the shortest amount of time” from the boxed warning.

Where it came from

2002. The Women’s Health Initiative published early results and the world panicked. The average woman in that trial was 63 — older than the age at which many women start treatment for hot flashes. Findings from that population got applied to healthy 51-year-olds who looked nothing like them.

Dr. Samantha Dunham(NYU Langone Health Center for Midlife Health and Menopause, HealthCentral, March 2026): the field is moving away from “low and slow — the lowest dose of estrogen for the shortest time.”

Dr. Stephanie Faubion(The Menopause Society / Mayo Clinic Center for Women’s Health): hormone therapy is the most effective treatment for menopause symptoms, and it’s vastly underutilized. Fewer than 4% of U.S. women ages 50–59 used hormone therapy in the cited data.

Dr. Lisa Larkin (San Antonio Breast Cancer Symposium, December 2025, Breastcancer.org, January 2026): flagged particular concern about messaging that overemphasizes benefits and minimizes risks for breast cancer survivors, where the data is genuinely unclear.

Low dose HRT is a real option for a specific woman under specific conditions. That’s a better story than “it’s all fine now,” and it has the advantage of being true.

The short-term evidence that low doses relieve symptoms is solid. The long-term outcome data at those specific doses over many years is thinner than at standard doses. That’s not a reason to avoid low dose — it’s a reason to keep a real clinician involved rather than treating this as set-and-forget.

Can women over 60 start low dose HRT online?

Age alone isn’t a disqualifier, but it changes the conversation. Updated labeling says to consider starting systemic HRT in women under 60 or within 10 years of menopause onset. Some online providers set their own age limits regardless.

It’s not a no.The FDA’s language is “consider” — it identifies a window where the balance is more favorable, not a wall.

Two things change:

The clinical conversation gets more individualized. Risks are greater when hormone therapy is initiated in older women and in those further from menopause onset. That doesn’t end the discussion — it means a longer one, probably in person.

Some providers won’t see you at all. Winona states it provides HRT treatment plans only to women ages 35–59.If you’re 60, that’s a business policy — and you’ll find out at intake.

If you’re over 60: Midi and Sesame both offer live video visits. If your history is at all complicated, an in-person clinician who can order what they need is the better starting point.

Find My HRT Path →

Asks your age and flags provider restrictions before you waste a consult fee.

Which online HRT providers publish a real follow-up plan?

Most online menopause providers can prescribe low-dose HRT. They differ on two things that matter more than the monthly price: whether they prescribe FDA-approved finished products or compounded formulations, and what they publish about follow-up and dose adjustment.

Given what the Divigel data showed, this is the table we’d want if we were you.

ProviderFirst check-inMessagingLive video?Guaranteed response time
Midi HealthLive initial and continued-care visits; platform messaging✓ Yes✓ Yes, 30-min initialNot published. Confirm how dose changes are handled between visits
SesameVideo visits as needed✓ Unlimited✓ Yes — you pick the providerNot published. Advertises easy treatment adjustments
WinonaProvider-stated 10-week check-in✓ Secure portal, included✕ Async onlyNot published. Portal access ≠ guaranteed clinician response time
HersRegular check-ins, timing not publicly specified✓ Unlimited provider messagingNot verifiedNot published
Inner BalanceUnresolved — their own pages conflict✓ Unlimited follow-up claimedNot verifiedNot published

Compiled from each provider’s published materials. Accessed . Cells marked “not published” mean we could not find an official source, not that no policy exists.

Notice what’s missing from every row. Not one of these providers publishes a guaranteed turnaround for a dose change. That’s not a knock — it’s an industry norm. The provider who gives you a straight answer at intake is telling you something.

Why we’re ordering it this way

Compounded formulations don’t have dose-response data at their custom strength. ACOG’s position is that compounded menopausal hormone therapy shouldn’t routinely be prescribed when FDA-approved formulations exist. That’s why the low-dose question is the one where FDA-approved products matter most. Our compounded vs. FDA-approved guide →

Midi Health

Strongest first comparison for in-network PPO members

The punchline: Live video with a clinician, prescribes FDA-approved hormone options, in network with most major PPOs, and your prescription goes to your own pharmacy — so your insurance can apply to the medication too.

Published pricing:$250 initial self-pay visit, generally $150 for continued care. With an accepted PPO, you’d pay your plan’s cost-sharing instead.

Best for you if:

  • ✓ You have PPO insurance
  • ✓ You want a real 30-minute video visit
  • ✓ You want FDA-approved medication specifically
  • ✓ You want to fill at your own pharmacy

Not for you if:

  • ✕ You have Medicare (not covered)
  • ✕ You have Medicaid or Medi-Cal (Midi cannot treat you)
  • ✕ You want the lowest cash consult fee — $250 is not it

Those exclusions aren’t small. If Medicare or Medicaid is you, go to Sesame — it doesn’t bill insurance at all, so there’s nothing to be excluded from.

What a patient said: “Midi was so easy: I got a same day appointment and they took my insurance.” — Published by Midi, not independently verified by us. Not a claim about typical results.

Check whether Midi is in-network with your plan →

Sesame

Cash-pay care with a local-pharmacy prescription

The punchline:$59/month care subscription. Video visits with a provider you choose, unlimited messaging, basic lab work included if your provider determines it’s necessary, and your prescription goes to your local pharmacy. Medication is separate.

Best for you if:

  • ✓ You’re paying cash, or have a high deductible
  • ✓ You have Medicare or Medicaid
  • ✓ You want to pick your own provider
  • ✓ You want your prescription at your own pharmacy

Not for you if:

  • ✕ You want one predictable all-in number ($59 doesn’t include medication)
  • ✕ You want insurance billed for you
  • ✕ You specifically want menopause-only clinical staff

What a patient said: “the first provider happily willing to go through the research and my concerns.” — Published by Sesame, not independently verified by us.

See Sesame’s current $59 care subscription →

Winona

Bundled and shipped, with real limits you need to know first

Read these three things before anything else:

  1. Winona states it provides HRT treatment plans only to women ages 35–59.If you’re 60 or older, this isn’t your provider.
  2. Winona lists 37 states plus Puerto Rico. Not nationwide. Check yours.
  3. Cancellation has a 24-hour window.Orders can be cancelled for a full refund only during the mandatory 24-hour processing window. After that, prepared prescription orders can’t be cancelled or refunded.

The punchline: One price, one box, shipped. The estradiol patch is $149/month with the consult, secure portal messaging, and shipping included. A 10-week check-in is scheduled.

On FDA approval — the distinction is real:

  • Estradiol patch: from $149/month.Winona states it’s FDA-approved. Their public page doesn’t identify the finished product or manufacturer, so we’re marking this provider-stated rather than independently verified. Ask for the product name at intake.
  • Estrogen + progesterone body cream: from $89/month. Compounded. The finished cream is not FDA-approved. An approved ingredient does not make an approved product.

Best for you if:

  • ✓ You’re 35–59, in a listed state, paying cash
  • ✓ You’ve been dismissed twice and can’t face another waiting room
  • ✓ You want physician messaging built into the price
  • ✓ You want the patch without pharmacy logistics

Not for you if:

  • ✕ You’re 60 or older — they won’t treat you
  • ✕ You’re not in one of the 37 states
  • ✕ You want live video
  • ✕ You want to use insurance

On price, honestly.Winona’s patch is $149/month, everything in. Published cash-price data lists generic estradiol transdermal patches, 0.025 mg/24hr twice-weekly, at approximately $36 for a 30-day supply of 8 patches before insurance. That’s a real gap — but Winona’s price includes the consult, messaging, and shipping, and we haven’t verified that Winona dispenses that same manufacturer’s patch. Check yours before you assume either number applies.

Check Winona’s age and state eligibility →

Hers

Lower monthly-equivalent pricing, with a 12-month commitment

The punchline: Estradiol and progesterone treatment from $79/month oral or $134/month for the patch — both figures are monthly-equivalent on a 12-month plan.

Read the terms. Cancellation takes effect at the end of the current period and must be submitted at least two days before the renewal processing date. For someone who may adjust route or dose twice in year one, a 12-month structure is real friction.

One thing Hers discloses that almost nobody else does: Hers states its hormone replacement regimens are not FDA-approved specifically for treating perimenopause, and may be prescribed off-label for perimenopausal symptoms at a clinician’s discretion. If you’re still having periods, that applies to you — and the fact that Hers says so while competitors don’t is worth noticing.

Best for you if:

  • ✓ You already know your route and don’t expect to switch
  • ✓ You want the lowest monthly-equivalent bundled price
  • ✓ You’re comfortable in an app-based program

Not for you if:

  • ✕ You want month-to-month flexibility
  • ✕ You’re in a state Hers doesn’t serve (list not publicly verified)
Check Hers’ state availability and 12-month plan terms →

Inner Balance (Oestra)

Compounded, with unresolved questions

The punchline: Estradiol and progesterone compounded into a single daily cream. Published pricing roughly $199/month for the first six months, then around $99.50/month. The finished Oestra product is compounded and is not FDA-approved.

Three things we could not resolve:

  1. State availability.Inner Balance’s own pages have said both 50 states plus D.C. and 43 states plus D.C. We can’t tell you which is current.
  2. Which pharmacy dispenses it.Their own pages describe Oestra as compounded through a 503A pharmacy in one place and a 503B outsourcing facility in another — different regulatory categories. We’re not publishing either until they say which.
  3. Follow-up cadence.One official article says they wait until month 4 to raise a dose. Another describes monthly adjustment. On a page about who actually follows up, that’s not a small gap.

We have not independently substantiated Inner Balance’s claims about absorption, side effects, whole-body results, endometrial protection, or its compounding category. Treat those as marketing until they’re verified. And don’t assume compounded vaginal progesterone provides endometrial protection equivalent to an FDA-approved regimen.

Review Oestra’s compounded-product status and current terms →

Which one is you?

Find your row. One action each — you’ve already done the comparing.

This sounds like meStart withConfirm before you pay
PPO insurance, want a real video visitMidi Health →Network status, cost-sharing, formulary, between-visit dose changes
Paying cash, want a local pharmacySesame →What labs are included, provider availability
Medicare or MedicaidSesame →Sesame doesn’t bill insurance — confirm cash-pay with your clinician
35–59, in a listed state, want it shippedWinona →Your state, the 24-hour cancellation window, the exact patch product
Route settled, want lowest monthly-equivalentHers →The 12-month terms, your state, the exact product
Specifically want one compounded creamInner Balance →Your state, which pharmacy, follow-up cadence
60 or olderLive video — Midi or SesameWinona won’t treat you. Consider in-person if history is complex
Only vaginal symptomsVaginal estrogen guide →You may not need systemic at all
Honestly not sureFind My HRT Path →Answer the safety questions honestly

Which providers serve your state?

State availability differs by provider and changes. Midi states it operates in all 50 states. Winona lists 37 states plus Puerto Rico. Hers states menopause care isn’t available in all 50 states without publishing a complete list. Inner Balance’s own pages conflict. Confirm your state on the provider’s current eligibility flow before paying.

This is the fastest way to waste a consult fee, so check it first.

ProviderPublished state coverageStatus
Midi HealthStates all 50 statesProvider-stated
SesameMarketplace model; provider availability variesCheck your state in their flow
Winona37 states plus Puerto RicoProvider-stated, published list
Hers"Not available in all 50 states" — no complete public list foundUnresolved
Inner BalanceTheir own pages say both 50 + D.C. and 43 + D.C.Unresolved — conflicting official sources

Accessed . State lists change. Verify in the provider’s current eligibility flow.

Find My HRT Path asks your state first — so you don’t get to checkout before finding out.

Do online HRT providers require lab tests?

There’s no single lab rule. Divigel’s label states that serum FSH and estradiol levels have not been shown useful for managing moderate-to-severe hot flashes. Clinicians may still order labs for other diagnostic or safety reasons.

“Do I need labs to prove I’m in menopause?” No test confirms perimenopause. Hormone levels swing day to day.

“Do I need labs before starting HRT?” Maybe — but not to pick your hot flash dose. Your clinician may want labs to check other causes or for safety reasons specific to your history.

ProviderPublished lab position
Midi HealthMay order blood work or imaging as the clinician determines. Exact included-lab policy not verified.
SesameBasic lab work included if the selected provider determines it's necessary, subject to program terms.
WinonaStates bloodwork isn't required to be prescribed a treatment plan.
HersNot publicly specified.
Inner BalanceNot publicly specified.

Accessed .

Ask: Are labs required for me or just available? Included in the price? Can I use recent results? What happens if something comes back needing in-person follow-up?

How do cancellation, refunds, and prescription transfers work?

Cancellation terms differ sharply and are rarely on the pricing page. Winona allows full refund only within a mandatory 24-hour order processing window. Hers’ general terms require cancellation at least two days before the renewal processing date. Confirm at checkout.

Nobody reads this until they need it. Read it now.

ProviderWhat we found
WinonaFull refund only during the 24-hour order processing window. After that, prepared prescription orders can't be cancelled or refunded. Subscription can be cancelled for future refills.
HersGeneral terms: cancellation effective at end of current period, submitted at least 2 days before renewal processing. Confirm the menopause plan uses this term.
Midi HealthFee-for-service visits — no subscription to cancel.
SesameMonthly subscription — confirm cutoff at checkout.
Inner BalanceStates "cancel anytime." Confirm the cutoff, refund treatment, and what happens to an order already at the pharmacy.

Accessed .

One thing worth understanding about the two models. If your prescription goes to your own pharmacy (Midi, Sesame), it’s yours — you can generally transfer it, and leaving the platform doesn’t strand your medication. If it’s bundled and shipped, leaving means starting over somewhere else. That’s not a reason to avoid bundled care. It’s a reason to know which one you picked.

What does low dose HRT online cost?

Online HRT has separate care, medication, lab, shipping, and plan-length costs. Published care fees range from Sesame’s $59/month subscription with medication separate, to Midi’s $250 initial and $150 continued self-pay visits. Bundled plans that include medication publish monthly-equivalent prices from approximately $79 upward.

Two structurally different models. Most pages blur them.

Model A — prescription goes to your own pharmacy

You can apply insurance or a discount card to the medication.

ProviderCare costMedicationInsurance?
Midi HealthYour PPO cost-sharing, or $250 initial / $150 continued self-paySeparate — at your pharmacy✓ Most PPOs · ✕ Medicare · ✕ Medicaid
Sesame$59/month subscriptionSeparate — at your pharmacy✕ Doesn’t bill insurance

Model B — bundled and shipped

Medication included. Insurance generally doesn’t apply.

ProviderPublished monthlyProduct status
Winona — estradiol patch$149FDA-approved per Winona; exact finished product not identified
Winona — E+P creamfrom $89Compounded — not FDA-approved
Hers — patchfrom $134 (12-month plan)Exact finished product not identified
Hers — oralfrom $79 (12-month plan)Exact finished product not identified
Inner Balance~$199 → ~$99.50 after 6 monthsCompounded — not FDA-approved

Provider pricing from each company’s published materials. Accessed .

What to actually budget for your first 90 days

90 days: an intake, a few fills, and an early follow-up — the window where you learn something.

ItemMidi (PPO)Sesame (cash)Winona (patch)
Care — confirmedCost-sharing per your plan$59 × 3 = $177Included
MedicationSeparate — variesSeparate — variesIncluded
Follow-upCost-sharingIncludedIncluded
LabsIf ordered — variesIncluded if provider determines necessaryNot required per Winona
Shippingn/an/aIncluded
CommitmentNoneMonthlyPer order; 24-hr cancel window
90-day care totalCost-sharing only$177 + medication~$447 all-in

As of , published cash-price data lists generic estradiol transdermal patches, 0.025 mg/24hr twice-weekly, at approximately $36 for a 30-day supply of 8 patchesbefore insurance. That’s one snapshot from one source. Look yours up before you build a budget on it.

Brand vs. generic.Brand-name patches can run several times the generic cash price. If a generic won’t stay on through a shower, it isn’t cheaper — it’s useless. Ask your prescriber whether a generic is a fit for your situation.

Insurance or a discount card — usually one or the other.A pharmacy claim generally processes either through your insurance or as a cash/coupon transaction. With a high deductible, the cash price sometimes beats the copay — ask your pharmacist to check both. One catch: a cash purchase typically doesn’t count toward your deductible.

Which provider claims could not be independently verified?

We check this so you don’t have to. When claims don’t reconcile, we publish that instead of picking one and hoping.

What’s unresolvedWhat we foundWhat it means for you
Winona's patch productWinona states the estradiol patch is FDA-approved. The public page doesn't name the finished product or manufacturer.Provider-stated, not independently verified. Ask for the product name at intake.
Hers' productsLists estradiol and progesterone. Exact finished products and manufacturers not identified publicly.Ask before you commit to 12 months.
Inner Balance's pharmacyTheir own pages say both 503A pharmacy and 503B outsourcing facility.Different regulatory categories. We won't publish either until they say which.
Inner Balance's statesTheir own pages say both 50 + D.C. and 43 + D.C.Confirm your state at source.
Inner Balance's follow-upOne official article says month 4 before raising a dose. Another says monthly.On a page about who follows up, that's the whole question.
Hers' state listStates 'not all 50' — no complete public list found.Don't assume. Check.
Every provider's response timeNot one publishes a guaranteed turnaround for a dose change.Ask at intake. The answer tells you a lot.

Accessed .

Why we publish this instead of smoothing it over: because you’re about to give one of these companies your medical history and your credit card. You should know exactly which claims we could stand behind and which we couldn’t.

What to verify before you pay

Free. No email. Screenshot it.

  1. 1What symptoms is this treatment labeled for?
  2. 2Is it systemic or local?
  3. 3What's the exact product name, manufacturer, and form?
  4. 4Is the finished product FDA-approved, or compounded?
  5. 5Who's the prescribing clinician, and are they licensed in my state?
  6. 6Which pharmacy fills it?
  7. 7Does the price include the medication?
  8. 8Are labs required, or offered? Included?
  9. 9When is my first dose check-in — and can I message before then?
  10. 10Can the prescription be transferred if I leave?
  11. 11What's the cancellation cutoff, exactly?
  12. 12If I have a uterus — what's the endometrial protection plan, and is it the labeled regimen or common practice?

Number 9 is the one nobody asks. Ask it. You know why now.

Two warnings on number 4:

  • An NDC number does not prove FDA approval. Compounded products can have them.
  • “FDA-approved ingredients” is not the same as an FDA-approved product. Neither is “FDA-registered pharmacy.” The FDA does not approve or license pharmacies — its own telehealth guidance flags that phrasing as misleading.

Ask it as a yes/no: “Is this finished product FDA-approved?”

Who should see someone in person first?

Online care isn’t the right starting point for every woman. Undiagnosed abnormal genital bleeding, a history of breast cancer or blood clots, liver disease, pregnancy, or significant diagnostic uncertainty may require in-person evaluation, examination, or imaging before any systemic hormone prescription is appropriate.

We’d rather lose the click than get this wrong.

Start in person if you have:

  • Vaginal bleeding you can't explain. The label requires ruling out cancer before systemic estrogen. Not 'consider' — requires.
  • Breast cancer, now or in the past, or estrogen-sensitive cancer
  • Blood clots (DVT, PE), stroke, or heart attack
  • Active liver disease
  • A known clotting disorder — protein C, protein S, or antithrombin deficiency
  • Any chance you're pregnant

Also worth starting in person:a breast lump or anything you’d want examined, symptoms nobody’s explained, or a complicated history where you want everything in one chart.

Emergency symptoms — chest pain, sudden shortness of breath, one-sided leg swelling, vision changes, sudden severe headache — call 911 or go now. Not an online form.

Find My HRT Path flags when online care isn’t your right first step and gives you a question list to bring to a clinician instead. No provider links in this section. On purpose.

What we actually verified

✓ Sources accessed :

  • ✓ FDA’s “Menopausal Hormone Therapies with Updated Prescribing Information” — six products listed
  • ✓ DIVIGEL prescribing information, revised 2/2026 — Table 3 efficacy and Table 2 exposure data
  • ✓ Which boxed warning language was removed and what was retained, from FDA’s own announcement
  • ✓ The Menopause Society’s public statement on the FDA change
  • ✓ Labeled strengths and indications for patch, gel, oral, and combination products from FDA and DailyMed
  • ✓ The progesterone capsule label’s endometrial protection regimen
  • ✓ Each provider’s published pricing, state availability, age policy, cancellation terms, and lab position

✕ What we did NOT do:

  • ✕ We have not signed up for these platforms. No firsthand patient experience to report.
  • ✕ We could not identify the exact finished products dispensed by Winona or Hers — marked provider-stated throughout
  • ✕ We could not resolve Inner Balance’s 503A/503B category, state count, or follow-up cadence — published as unresolved
  • ✕ We have not independently tested any compounded product’s potency
  • ✕ We have not verified a medication price that would be true for you — we’ve given one dated snapshot

How we do it: The HRT Index Verification Standard — read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule (top providers monthly, full roster quarterly).

Our five pillars, in order:clinical legitimacy · care quality · medication fit · price transparency · access. No scores. No stars. A number can’t tell you whether a provider fits your life.

Found something wrong? Tell us. We’ll check it and date the correction.

Frequently asked questions

What is the lowest dose of HRT?
There is no universal lowest dose. It is product-specific: some once-weekly patches start hot flash treatment at 0.025 mg/day, some twice-weekly patches at 0.0375 mg/day, Divigel at 0.25 mg, Bijuva at 0.5 mg/100 mg. The numbers do not transfer between products because different routes deliver differently.
Is a 0.025 mg estradiol patch low dose?
It depends which patch. Some once-weekly labels start vasomotor-symptom treatment at 0.025 mg/day. Some twice-weekly labels start at 0.0375 mg/day and use 0.025 mg/day for osteoporosis prevention instead. Ask what the labeled hot flash starting dose is for the exact patch you are prescribed.
Can I get low dose HRT online?
Yes, where telehealth is available and a licensed clinician determines treatment is appropriate for you. You still need a prescription, a real medical history review, and a follow-up plan. Any service skipping those is not one to use.
Is low dose HRT safer than a standard dose?
Not automatically. Dose is one factor among several — route, progestogen status, timing, and your personal history each affect the picture. Dose alone cannot rank two different situations.
Why does my patch still have a black box warning if the FDA removed it?
FDA approved labeling changes for six named products in February 2026, not for every manufacturer's product. As of July 14, 2026, the FDA's tracking page still lists six. Check the current label for the exact product you were dispensed — that is the one that applies to your medication.
How long does low dose HRT take to work?
It depends on the product, and most do not publish a week-by-week breakdown. Divigel does: its 0.25 mg dose did not reach statistical significance versus placebo on frequency or severity at week 4, but reached both by week 7. That is Divigel-specific and does not set a timeline for patches, pills, or you.
Do I need progesterone with low dose estrogen?
If you have a uterus and you are on systemic estrogen, you need endometrial protection at any dose. This is the boxed warning the FDA kept in 2026. The specific regimen is product-specific. After a hysterectomy, generally not, though a history of endometriosis can change that. Low-dose vaginal estrogen is different: The Menopause Society does not recommend adding a progestogen for it.
Is 100 mg of progesterone the standard dose?
Not per the label. The progesterone capsule label's regimen for endometrial protection is 200 mg at bedtime for 12 days per 28-day cycle with daily conjugated estrogen. 100 mg is a real capsule strength and is what is in Bijuva, an approved combination product — and 100 mg daily is a common clinical practice. But practice and the labeled regimen are not the same, and you should know which you are being prescribed.
Is low dose HRT enough for severe hot flashes?
It may or may not be. In the Divigel trial, the 0.25 mg group had a smaller median severity change at week 12 (−0.33) than the 1.0 mg group (−1.69), though both beat placebo (−0.13). If it is not controlling your symptoms, that is a reason to go back to your clinician — not a reason to assume a higher dose is automatically right.
Can I start low and increase later?
That is the design. Several labels direct clinicians to start at a specified strength and adjust based on response — though the instructions differ by product. The real question is not whether you can. It is what your provider's follow-up plan actually is.
Is low dose HRT the same as bioidentical HRT?
Different concepts. 'Bioidentical' describes molecular structure — many FDA-approved products are bioidentical. 'Compounded' describes how it is made and whether FDA reviewed it. A product can be bioidentical and FDA-approved, or bioidentical and compounded. Ask: is this finished product FDA-approved?
Can I take low dose HRT in perimenopause?
Hers states its hormone replacement regimens are not FDA-approved specifically for treating perimenopause and may be prescribed off-label at a clinician's discretion. That is legal and common. If you are still having periods, ask your provider about it directly.
Can I cut an estradiol patch in half?
Do not, unless your prescriber or pharmacist confirms it for your exact patch. Some are built so cutting changes how the drug releases. Ask first.
Does insurance cover low dose HRT?
Coverage and tier vary by plan, product, manufacturer, prior authorization rules, and pharmacy benefit. Generic estradiol and progesterone are commonly covered, but confirm your exact product with your insurer. Compounded products generally are not covered, and bundled subscriptions cannot be billed to insurance.

Still not sure which HRT program is right for you?

Low dose is a fine place to start. It’s only a destination if it works. The labeled starting strengths are real, evidence-backed places to begin. But the FDA’s own data shows the lowest dose of one gel took seven weeks to separate from placebo, moved severity less than higher doses, and produced very different measured exposure in different women. Most products don’t even publish that much.

So the thing that determines whether this works for you isn’t the dose you start on. It’s whether anyone checks. Pick a provider on that. Not on the monthly number.

Educational only. Find My HRT Path doesn’t diagnose anything, doesn’t recommend a dose, and doesn’t replace a licensed clinician. Because it asks about your health, we handle your answers under our consumer health data and privacy policy.

Sources

Regulatory

  1. FDA — Menopausal Hormone Therapies with Updated Prescribing Information. Content current as of 02/12/2026. Accessed .
  2. FDA — FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. .
  3. FDA — FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies. .
  4. FDA — DIVIGEL (estradiol gel) prescribing information, revised 2/2026. Sections 2.1, 4, 5.1, 5.2, 5.20, 12.2, 12.3 (Table 2), 14.1 (Table 3).
  5. DailyMed — estradiol transdermal system labels (once-weekly and twice-weekly), oral estradiol tablets, Menostar, Premarin, Bijuva, progesterone capsules. Accessed .
  6. FDA — Compounding and the FDA: Questions and Answers.
  7. FDA — FDA & Telehealth Companies: What to Know When Promoting Compounded Drugs.

Professional bodies

  1. The Menopause Society — Comments on the FDA Announcement on Hormone Therapy. .
  2. The Menopause Society — 2022 Hormone Therapy Position Statement. Menopause. 2022;29(7):767–794.
  3. ACOG — Compounded Bioidentical Menopausal Hormone Therapy. Clinical Consensus, .

Clinical commentary

  1. Dr. Samantha Dunham, NYU Langone Health Center for Midlife Health and Menopause, quoted in HealthCentral, “What Is the Lowest Dose of Estrogen for Menopause?” .
  2. Dr. Stephanie Faubion, The Menopause Society / Mayo Clinic Center for Women’s Health, quoted in the same HealthCentral article; Mayo Clinic utilization data.
  3. Dr. Lisa Larkin, San Antonio Breast Cancer Symposium, , reported in Breastcancer.org, “Experts React to Removal of Black Box Warning from HRT,” .

Provider sources (all accessed )

  1. Midi Health — pricing and insurance pages.
  2. Sesame — menopause treatment page.
  3. Winona — product page, FAQ, state availability page, and help center cancellation policy.
  4. Hers — menopause page, insurance blog, and terms and conditions.
  5. Inner Balance — product page and published articles.
  6. Published cash-price data, generic estradiol transdermal patch 0.025 mg/24hr twice-weekly, 8 films.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.